Johannes Wolff

11.4k total citations · 2 hit papers
231 papers, 7.5k citations indexed

About

Johannes Wolff is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Johannes Wolff has authored 231 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Genetics, 94 papers in Molecular Biology and 51 papers in Neurology. Recurrent topics in Johannes Wolff's work include Glioma Diagnosis and Treatment (100 papers), Neuroblastoma Research and Treatments (45 papers) and Cancer therapeutics and mechanisms (24 papers). Johannes Wolff is often cited by papers focused on Glioma Diagnosis and Treatment (100 papers), Neuroblastoma Research and Treatments (45 papers) and Cancer therapeutics and mechanisms (24 papers). Johannes Wolff collaborates with scholars based in United States, Germany and Canada. Johannes Wolff's co-authors include Stefan Rutkowski, Monika Warmuth‐Metz, Torsten Pietsch, R. Maarten Egeler, Astrid Gnekow, Brigitte Wrede, Sabine Wagner, Norbert Graf, Joachim Kühl and Jonathan L. Finlay and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Johannes Wolff

226 papers receiving 7.4k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

2005 505 citations Stefan Rutkowski, U. Bode et al. New England Journal of Medicine profile →
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011

2014 385 citations Johannes Wolff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johannes Wolff United States	44	3.7k	2.9k	1.7k	1.4k	1.2k	231	7.5k
Kevin Shannon United States	58	1.7k 0.5×	6.2k 2.1×	1.4k 0.8×	2.2k 1.6×	1.1k 0.9×	276	12.5k
Susan M. Blaney United States	63	2.5k 0.7×	5.0k 1.7×	2.8k 1.7×	3.3k 2.4×	3.0k 2.4×	267	11.4k
William Krivit United States	60	2.4k 0.6×	3.6k 1.3×	673 0.4×	1.7k 1.2×	1.4k 1.1×	279	14.6k
Elizabeth Fox United States	42	589 0.2×	1.9k 0.7×	1.7k 1.0×	2.0k 1.4×	1.4k 1.2×	220	5.8k
D. Niethammer Germany	52	822 0.2×	2.2k 0.8×	889 0.5×	2.3k 1.7×	491 0.4×	289	9.0k
Tomoki Naoe Japan	56	2.7k 0.7×	8.1k 2.8×	656 0.4×	2.9k 2.1×	575 0.5×	352	15.9k
Nicolás André France	50	744 0.2×	4.1k 1.4×	786 0.5×	2.8k 2.0×	1.2k 1.0×	264	8.6k
Andrew D.J. Pearson United Kingdom	54	1.5k 0.4×	5.4k 1.9×	6.9k 4.1×	2.3k 1.7×	814 0.7×	224	11.4k
Rogier M. Bertina Netherlands	64	3.6k 1.0×	2.2k 0.8×	271 0.2×	410 0.3×	1.5k 1.3×	250	16.3k
Kevin O. Lillehei United States	39	1.8k 0.5×	952 0.3×	833 0.5×	758 0.6×	886 0.7×	145	5.0k

Countries citing papers authored by Johannes Wolff

Since Specialization

Citations

This map shows the geographic impact of Johannes Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Wolff more than expected).

Fields of papers citing papers by Johannes Wolff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Wolff. The network helps show where Johannes Wolff may publish in the future.

Co-authorship network of co-authors of Johannes Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Wolff. A scholar is included among the top collaborators of Johannes Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Wolff. Johannes Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolff, Johannes, et al.. (2024). Bringing researchers together with IIIF. Art Libraries Journal. 49(1). 37–43.

Hauch, Holger, et al.. (2021). Out-of-Hospital Emergencies in Children Under Palliative Home Care. Frontiers in Pediatrics. 9. 734181–734181. 7 indexed citations

Borthakur, Gautam, Olatoyosi Odenike, Ibrahim Aldoss, et al.. (2021). A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia. Cancer. 127(16). 2943–2953. 51 indexed citations

Ottensmeier, Holger, Paul G. Schlegel, Matthias Eyrich, et al.. (2020). Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment. PLoS ONE. 15(1). e0227693–e0227693. 13 indexed citations

Piha‐Paul, Sarina A., Jasgit C. Sachdev, Minal Barve, et al.. (2019). First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors. Clinical Cancer Research. 25(21). 6309–6319. 116 indexed citations

Wei, Andrew H., Jacqueline S. Garcia, Uma Borate, et al.. (2019). A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome. Blood. 134(Supplement_1). 568–568. 39 indexed citations

Wolff, Johannes, Kamran Mohiuddin, Norbert Jorch, et al.. (2010). Measuring performance status in pediatric patients with brain tumors—experience of the HIT‐GBM‐C protocol. Pediatric Blood & Cancer. 55(3). 520–524. 2 indexed citations

Hasselblatt, Martin, Sonja Mertsch, Björn Koos, et al.. (2009). TWIST-1 Is Overexpressed in Neoplastic Choroid Plexus Epithelial Cells and Promotes Proliferation and Invasion. Cancer Research. 69(6). 2219–2223. 43 indexed citations

Wolff, Johannes, Carl Friedrich Classen, Sabine Wagner, et al.. (2008). Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. Journal of Neuro-Oncology. 87(2). 155–164. 31 indexed citations

10.

Classen, Carl Friedrich, et al.. (2006). LATE RESPONSE TO RADIOCHEMOTHERAPY IN PEDIATRIC GLIOBLASTOMA: Report on Two Patients Treated According to HIT-GBM Protocols. Pediatric Hematology and Oncology. 23(8). 631–637. 3 indexed citations

11.

Rutkowski, Stefan, U. Bode, Frank Deinlein, et al.. (2005). Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone. New England Journal of Medicine. 352(10). 978–986. 505 indexed citations breakdown →

12.

Rutkowski, Stefan, Monika Warmuth‐Metz, N. Sörensen, et al.. (2005). Hirntumoren im kindesalter. Diagnostik und interdisziplinäre therapiekonzepte. Der Onkologe. 11(10). 1090–1100. 2 indexed citations

13.

Wagner, Sabine, Bernhard Erdlenbruch, Alfred Längler, et al.. (2004). Oral topotecan in children with recurrent or progressive high‐grade glioma. Cancer. 100(8). 1750–1757. 16 indexed citations

14.

Kleinjung, Tobias, et al.. (2003). Langerhans’ cell histiocytosis with bilateral temporal bone involvement. American Journal of Otolaryngology. 24(4). 265–270. 28 indexed citations

15.

Knüpfer, M, et al.. (2000). INTERFERON GAMMA INHIBITS PROLIFERATION AND HYALURONIC ACID ADHESION OF HUMAN MALIGNANT GLIOMA CELLS IN VITRO. Cytokine. 12(4). 409–412. 8 indexed citations

16.

Kortmann, Rolf‐D., Joachim Kühl, Beate Timmermann, et al.. (2000). Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the german prospective randomized trial hit ’91. International Journal of Radiation Oncology*Biology*Physics. 46(2). 269–279. 302 indexed citations

17.

Knüpfer, M, et al.. (1998). Hyaluronic acid binding capacity of malignant glioma cells.. PubMed. 18(1A). 353–6. 4 indexed citations

18.

Knüpfer, M, et al.. (1997). Cisplatin induces radioprotection in human T98G glioma cells.. PubMed. 17(2A). 1131–4. 11 indexed citations

19.

Laterra, John, et al.. (1992). Formation and Differentiation of Brain Capillaries. PsycEXTRA Dataset. 120. 73–86. 2 indexed citations

20.

Wright, D. J. & Johannes Wolff. (1969). Trans –aconitic acid and the magnesium status of Guinea Pigs and Sheep. New Zealand Journal of Agricultural Research. 12(2). 287–292. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact